Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N4FX
|
||||
| Drug Name |
Ranolazine extended-release
|
||||
| Synonyms |
CVT 303; CVT 3041; KEG 1295; RAN D; Ran4; Ranexa; Ranolazine hydrochloride; RS 43285; RS 43285-003; RS 43285-193
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Unspecified | Approved | [551871] | ||
| Therapeutic Class |
Cardiovascular Agents
|
||||
| Formula |
C24H33N3O4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Plasminogen | Target Info | Modulator | [532368] | |
| PANTHER Pathway | Blood coagulation | ||||
| Plasminogen activating cascade | |||||
| PathWhiz Pathway | Coagulation | ||||
| WikiPathways | Complement and Coagulation Cascades | ||||
| Human Complement System | |||||
| Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
| Activation of Matrix Metalloproteinases | |||||
| Blood Clotting Cascade | |||||
| Dissolution of Fibrin Clot | |||||
| Folate Metabolism | |||||
| Vitamin B12 Metabolism | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.